Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02934464 |
|---|---|
| Brief Title: | Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers (ARMANI) |
| First Submitted : | October 6, 2016 |
| First Submitted that Met QC Criteria : | October 13, 2016 |
| First Posted : | October 17, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | September 3, 2021 |
| Last Update Posted : | September 13, 2021 |